** Shares of Aroa Biosurgery ARX.AX fall 18.1% to A$0.655, on track for their biggest-ever intraday drop
** Wound healing products maker fell as much as 19.1% earlier in the day, hitting lowest level since Dec. 18
** Co cuts FY25 normalised EBITDA profit guidance to a range between NZ$2 mln ($1.13 mln) and NZ$4 mln, from earlier guidance of NZ$2 mln to NZ$6 mln
** Cuts FY25 total revenue guidance to between NZ$81 mln and NZ$84 mln from earlier guidance of NZ$80 mln to NZ$87 mln
** About 901,488 shares change hand, compared to 30-day average trading volume of 318,195 shares
** Stock down around 15% this year, including the day's moves
($1 = 1.7680 New Zealand dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。